RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Cape Investment Advisory, Inc.'s Holding History (CIK: 0001944437)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 350 Value ($000) $2 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 350 Value ($000) $2 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 350 Value ($000) $2 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 504 Value ($000) $3 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 350 Value ($000) $2 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 350 Value ($000) $3 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 350 Value ($000) $3 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 350 Value ($000) $3 Avg Close $7.13 Range $4.97 - $11.17
Q2 2023
Shares 250 Value ($000) $2 Avg Close $7.00 Range $4.54 - $10.45
Q1 2023
Shares 250 Value ($000) $2 Avg Close $7.93 Range $6.40 - $9.73